INS and metabolic syndrome: Patients with high levels of apoB have a higher BMI, waist circumference, systolic blood pressure, fasting insulin and C-reactive protein, which are all components of MetS [134], and epidemiological studies show that apoB predicts the development of type 2 diabetes as much as 3–10 years in advance of clinical onset [135].